Ginkgo Bioworks to go public in SPAC deal worth over $1.6B

By The Science Advisory Board staff writers

Cell programming company Ginkgo Bioworks will go public after it finalizes a $1.6 billion deal with Soaring Eagle Acquisition, a special purpose acquisition company (SPAC).

The deal was approved by Soaring Eagle's shareholders on September 14. Subject to customary closing conditions, Soaring Eagle anticipates that the deal with Gingko will close on September 16. Following closing, Soaring Eagle will change its name to Ginkgo Bioworks Holdings.

The combined company's shares of class A common stock and public warrants are expected to begin trading on the New York Stock Exchange on September 17, 2021, under the ticker symbols DNA and DNA.WS, respectively.

Copyright © 2021

To read this and get access to all of the exclusive content on The Science Advisory Board create a free account or sign-in now.

Member Sign In:
MemberID or email address:  
Do you have a password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?